Methods for reducing the risk of an adverse teriflunomide and rosuvastatin interaction in multiple sclerosis patients | Patent Number 09186346
US 09186346 B2Filled DateFeb 4, 2014
Priority DateMar 12, 2013
Publication DateSep 11, 2014
Expiration DateMar 11, 2033
Inventor/ApplicantsDietmar WEITZ
Sandrine Turpault
Pierre-Francois CLOT
Francoise Menguy-Vacheron
Dietmar Weitz
Pierre-Francois Clot
Sandrine TURPAULT
Francoise MENGUY-VACHERON
Sandrine Turpault
Pierre-Francois CLOT
Francoise Menguy-Vacheron
Dietmar Weitz
Pierre-Francois Clot
Sandrine TURPAULT
Francoise MENGUY-VACHERON
ExaminesTRAN, MY CHAU T
Art Unit1629
Technology Center1600
Assignments
Law Firm
You must be logged in to view
LoginAttorneys
Subscription-Only
View Concierge Program
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.